These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 38794251)

  • 1. QbD Approach-Based Preparation and Optimization of Hydrophobic Ion-Pairing Complex of Lysozyme with Sodium Dodecyl Sulphate to Enhance Stability in Lipid-Based Carriers.
    Hassan AAA; Sovány T; Pamlényi K; Deák M; Hornok V; Csapó E; Regdon G; Csóka I; Kristó K
    Pharmaceutics; 2024 Apr; 16(5):. PubMed ID: 38794251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and optimization of metformin hydrophobic ion pairs for efficient encapsulation in polymeric drug carriers.
    Abd-El Hafeez SI; Eleraky NE; Hafez E; Abouelmagd SA
    Sci Rep; 2022 Apr; 12(1):5737. PubMed ID: 35388027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel approach for antibody nanocarriers development through hydrophobic ion-pairing complexation.
    Patel A; Gaudana R; Mitra AK
    J Microencapsul; 2014; 31(6):542-50. PubMed ID: 24697179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality by design (QbD) optimization of diazepam-loaded nanostructured lipid carriers (NLC) for nose-to-brain delivery: Toxicological effect of surface charge on human neuronal cells.
    Costa CP; Cunha S; Moreira JN; Silva R; Gil-Martins E; Silva V; Azevedo L; Peixoto AF; Sousa Lobo JM; Silva AC
    Int J Pharm; 2021 Sep; 607():120933. PubMed ID: 34324988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality by Design: Development of the Quality Target Product Profile (QTPP) for Semisolid Topical Products.
    Namjoshi S; Dabbaghi M; Roberts MS; Grice JE; Mohammed Y
    Pharmaceutics; 2020 Mar; 12(3):. PubMed ID: 32210126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality by Design-Guided Systematic Development and Optimization of Mucoadhesive Buccal Films.
    Hassan AAA; Kristó K; Ibrahim YHY; Regdon G; Sovány T
    Pharmaceutics; 2023 Sep; 15(10):. PubMed ID: 37896135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimization of the manufacturing process of a complex amphotericin B liposomal formulation using quality by design approach.
    Liu H; Rivnay B; Avery K; Myung JH; Kozak D; Landrau N; Nivorozhkin A; Ashraf M; Yoon S
    Int J Pharm; 2020 Jul; 585():119473. PubMed ID: 32473373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of Silicone-Containing Semisolid in Situ Film-Forming Systems Using QbD Tools.
    Kis N; Kovács A; Budai-Szűcs M; Gácsi A; Csányi E; Csóka I; Berkó S
    Pharmaceutics; 2019 Dec; 11(12):. PubMed ID: 31817871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. QbD-guided pharmaceutical development of Pembrolizumab biosimilar candidate PSG-024 propelled to industry meeting primary requirements of comparability to Keytruda®.
    Jaffar-Aghaei M; Khanipour F; Maghsoudi A; Sarvestani R; Mohammadian M; Maleki M; Havasi F; Rahmani H; Karagah AH; Kazemali MR
    Eur J Pharm Sci; 2022 Jun; 173():106171. PubMed ID: 35378209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of nanostructured lipid carriers containing salicyclic acid for dermal use based on the Quality by Design method.
    Kovács A; Berkó S; Csányi E; Csóka I
    Eur J Pharm Sci; 2017 Mar; 99():246-257. PubMed ID: 28012940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality by Design (QbD)-enabled development of aceclofenac loaded-nano structured lipid carriers (NLCs): An improved dermatokinetic profile for inflammatory disorder(s).
    Garg NK; Sharma G; Singh B; Nirbhavane P; Tyagi RK; Shukla R; Katare OP
    Int J Pharm; 2017 Jan; 517(1-2):413-431. PubMed ID: 27956192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimizing Process Parameters for Controlled Drug Delivery: A Quality by Design (QbD) Approach in Naltrexone Microspheres.
    Reddy PL; Shanmugasundaram S
    AAPS PharmSciTech; 2024 May; 25(5):105. PubMed ID: 38724807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding pharmaceutical quality by design.
    Yu LX; Amidon G; Khan MA; Hoag SW; Polli J; Raju GK; Woodcock J
    AAPS J; 2014 Jul; 16(4):771-83. PubMed ID: 24854893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality by design (QbD)-based fabrication of atazanavir-loaded nanostructured lipid carriers for lymph targeting: bioavailability enhancement using chylomicron flow block model and toxicity studies.
    Gurumukhi VC; Bari SB
    Drug Deliv Transl Res; 2022 May; 12(5):1230-1252. PubMed ID: 34110597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality by Design: Concept to Applications.
    Swain S; Parhi R; Jena BR; Babu SM
    Curr Drug Discov Technol; 2019; 16(3):240-250. PubMed ID: 29521238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. QbD based development of proliposome of lopinavir for improved oral bioavailability.
    Patel GM; Shelat PK; Lalwani AN
    Eur J Pharm Sci; 2017 Oct; 108():50-61. PubMed ID: 27586019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of Bedaquiline-Loaded SNEDDS Using Quality by Design (QbD) Approach to Improve Biopharmaceutical Attributes for the Management of Multidrug-Resistant Tuberculosis (MDR-TB).
    Jahan RN; Khan Z; Akhtar MS; Ansari MD; Solanki P; Ahmad FJ; Aqil M; Sultana Y
    Antibiotics (Basel); 2023 Oct; 12(10):. PubMed ID: 37887211
    [No Abstract]   [Full Text] [Related]  

  • 18. Development and in vitro evaluation of pH-independent release matrix tablet of weakly acidic drug valsartan using quality by design tools.
    Saydam M; Takka S
    Drug Dev Ind Pharm; 2018 Dec; 44(12):1905-1917. PubMed ID: 29969042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality by Design (QbD) Approach for a Nanoparticulate Imiquimod Formulation as an Investigational Medicinal Product.
    Pielenhofer J; Meiser SL; Gogoll K; Ciciliani AM; Denny M; Klak M; Lang BM; Staubach P; Grabbe S; Schild H; Radsak MP; Spahn-Langguth H; Langguth P
    Pharmaceutics; 2023 Feb; 15(2):. PubMed ID: 36839835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A quality by design (QbD) study on enoxaparin sodium loaded polymeric microspheres for colon-specific delivery.
    Hales D; Vlase L; Porav SA; Bodoki A; Barbu-Tudoran L; Achim M; Tomuță I
    Eur J Pharm Sci; 2017 Mar; 100():249-261. PubMed ID: 28088371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.